Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Smart Monitoring Assessing Spasticity-related HealthRecruiting
NCT06937723N/AUpdated Apr 22, 2025
Sponsor: Heinrich-Heine University, Duesseldorf
Multiple Sclerosis
Germany
COMparison Between All immunoTherapies for Multiple Sclerosis.Completed
NCT03193866N/AUpdated Apr 20, 2025
Sponsor: Karolinska Institutet
Relapsing-remitting Multiple Sclerosis
Sweden
Proximal Resistance Training for People With Multiple SclerosisCompleted
NCT04548154NAUpdated Apr 18, 2025
Sponsor: University of Colorado, Denver
Multiple Sclerosis
United States
Reliability of Kinovea in Gait Assessment in Multiple Sclerosis: a Pilot Study.Completed
NCT06928194N/AUpdated Apr 18, 2025
Sponsor: University of Cadiz
Multiple Sclerosis · Gait Disorders, Neurologic
Spain
Pelvic Proprioceptive Neuromuscular Facilitation (PNF) Exercises in Multiple Sclerosis PatientsCompleted
NCT06198972NAUpdated Apr 17, 2025
Sponsor: Kahramanmaras Sutcu Imam University
Multiple Sclerosis
Turkey (Türkiye)
Prospective Stratification of Infectious Risks in Multiple SclerosisCompleted
NCT04036097N/AUpdated Apr 17, 2025
Sponsor: University Hospital, Basel, Switzerland
Multiple Sclerosis
Switzerland
Exploring Pathology Related to Slowly Expanding Lesions Using Advanced ImagingEnrolling By Invitation
NCT06460077N/AUpdated Apr 16, 2025
Sponsor: Turku University Hospital
Multiple Sclerosis
Finland
A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple SclerosisActive Not Recruiting
NCT06396039Phase 4Updated Apr 16, 2025
Sponsor: Bristol-Myers Squibb
Relapsing Multiple Sclerosis
China
Portable Neuromodulation Stimulator Registry for People With Multiple SclerosisActive Not Recruiting
NCT06930339N/AUpdated Apr 16, 2025
Sponsor: Helius Medical Inc
Multiple Sclerosis
United States
Swiss Multiple Sclerosis Cohort-StudyRecruiting
NCT02433028N/AUpdated Apr 14, 2025
Sponsor: University Hospital, Basel, Switzerland
Multiple Sclerosis
Switzerland
Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of ProgressionActive Not Recruiting
NCT03368677N/AUpdated Apr 13, 2025
Sponsor: Turku University Hospital
Multiple Sclerosis
Finland
Impact of the Modifications of Environmental Exposures and Health Care Access During COVID-19 Lockdown on Multiple SclerosisCompleted
NCT05033782N/AUpdated Apr 13, 2025
Sponsor: Assistance Publique - Hôpitaux de Paris
Multiple Sclerosis
France
TENS in Persons With MSCompleted
NCT05321927NAUpdated Apr 10, 2025
Sponsor: University Medical Center Groningen
Multiple Sclerosis
Netherlands
Clinical Investigation of the Quality of Life Benefit of Using a Home Walking Exoskeleton for a Population of Multiple Sclerosis Patients.Recruiting
NCT05835622NAUpdated Apr 9, 2025
Sponsor: Pôle Saint Hélier
Multiple Sclerosis
France
Effects of Sailing and Cooing in the Quality of Life of Multiple Sclerosis IndividualsCompleted
NCT06915272NAUpdated Apr 8, 2025
Sponsor: University of Thessaly
Multiple Sclerosis (MS) - Relapsing-remitting
Greece
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MSRecruiting
NCT05003388Phase 1Updated Apr 8, 2025
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Multiple Sclerosis
Antigua and Barbuda, Greece
Quantified Balance Measures During Stance and Gait: Multiple Sclerosis Patients. A Longitudinal Clinical StudyRecruiting
NCT02142946N/AUpdated Apr 6, 2025
Sponsor: University Hospital, Basel, Switzerland
Balance Control
Switzerland
Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple SclerosisRecruiting
NCT06068582NAUpdated Apr 3, 2025
Sponsor: Amsterdam UMC, location VUmc
Multiple Sclerosis
Netherlands
Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone AdministrationEnrolling By Invitation
NCT06223074Phase 2Updated Apr 3, 2025
Sponsor: Universidad Nacional Autonoma de Mexico
Multiple Sclerosis Relapsing Remitting · Treatment
Mexico
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune DiseasesRecruiting
NCT06794008Phase 2Updated Apr 2, 2025
Sponsor: Peking University People's Hospital
Systemic Lupus Erythematosus · Inflammatory Myopathy · Systemic Sclerosis (SSc) · ANCA-associated Vasculitis
China
The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple SclerosisRecruiting
NCT06016309N/AUpdated Mar 30, 2025
Sponsor: University Medical Center Groningen
Multiple Sclerosis
Netherlands
Melatonin in Patients With Multiple Sclerosis (MS).Completed
NCT03498131EARLY_Phase 1Updated Mar 30, 2025
Sponsor: Providence Health & Services
Relapsing Remitting Multiple Sclerosis
United States
Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple SclerosisCompleted
NCT01093326Phase 2Updated Mar 30, 2025
Sponsor: Actelion
Multiple Sclerosis
United States, Austria, Bulgaria, Canada, Czechia +15 more
Probiotic Chocolate Study in Multiple SclerosisCompleted
NCT06475183NAUpdated Mar 30, 2025
Sponsor: Columbia University
Multiple Sclerosis · Healthy Nutrition
United States
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple SclerosisCompleted
NCT02425644Phase 3Updated Mar 30, 2025
Sponsor: Actelion
Multiple Sclerosis
United States, Belarus, Bosnia and Herzegovina, Bulgaria, Canada +23 more

Previous page Next page